Neurocrine Biosciences Files 8-K on Officer/Director Changes
Ticker: NBIX · Form: 8-K · Filed: May 30, 2025 · CIK: 914475
| Field | Detail |
|---|---|
| Company | Neurocrine Biosciences Inc (NBIX) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, financial-statements
Related Tickers: NBIX
TL;DR
NBI leadership changes and financial updates filed today.
AI Summary
Neurocrine Biosciences, Inc. filed an 8-K on May 30, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's leadership and governance structure, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: low — The filing is routine and reports on corporate governance and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- NEUROCRINE BIOSCIENCES, INC. (company) — Registrant
- May 30, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 6027 Edgewood Bend Court, San Diego, California 92130 (address) — Address of Principal Executive Offices
- ( 858 ) 617-7600 (phone_number) — Registrant's telephone number
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and roles are not detailed in the provided text.
Are there any new financial statements included with this filing?
Yes, the filing explicitly states 'Financial Statements and Exhibits' are included.
What is the primary business of Neurocrine Biosciences, Inc. according to the filing?
The company is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code [2836].
When was the report filed with the SEC?
The report was filed on May 30, 2025.
What is the state of incorporation for Neurocrine Biosciences, Inc.?
The company is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding NEUROCRINE BIOSCIENCES INC (NBIX).